Oklo Inc. Form 8-K Summary
Business Context and Reporting Period
Oklo Inc., an emerging growth company incorporated in Delaware, filed this Current Report on Form 8-K on December 4, 2025. The filing reports the entry into a material definitive agreement to establish an "at-the-market" equity distribution program.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses exclusively on the authorization of a potential capital raise.
Material Changes and Agreements
- Equity Distribution Agreement: On December 4, 2025, Oklo entered into a Sales Agreement with nine sales agents, including Goldman Sachs, BofA Securities, Citigroup, Morgan Stanley, Barclays, TD Securities, Guggenheim, B. Riley Securities, and William Blair.
- Offering Capacity: The Company may offer and sell shares of Class A Common Stock with aggregate gross proceeds of up to $1,500,000,000.
- Sale Method: Sales may be conducted through ordinary brokers' transactions, market makers, the New York Stock Exchange, over-the-counter markets, or block trades at prevailing market prices or negotiated prices.
- Compensation: The Company will pay the Sales Agents a commission of up to 1.5% of the gross sales price per share and reimburse certain expenses.
- Registration: Shares will be issued pursuant to a shelf registration statement on Form S-3 (File No. 333-291157), declared effective on December 4, 2025.
Guidance, Outlook, and Risks
The filing does not provide specific financial guidance, management commentary on operational outlook, or a discussion of risks beyond standard legal disclaimers. The agreement allows the Company to suspend sales if they cannot be effected at or above a designated price. The Sales Agreement includes customary representations, warranties, covenants, and indemnification provisions.
Key Facts for Investor Verification
- Verify the total number of shares outstanding and the potential dilution impact if the full $1.5 billion capacity is utilized.
- Monitor the prospectus supplement to be filed with the SEC for specific terms regarding minimum sale prices and daily volume limits.
- Review the Company's current cash position and burn rate to assess the immediate necessity of this capital raise.
- Confirm the status of the Form S-3 shelf registration statement (File No. 333-291157) and any subsequent amendments.